PM

Prasad Malurpatna Puttasiddaiah

Director DIN 01110656
DIN 01110656 First appointment Oct 2004
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Oct 2004
Shareholding value β€’β€’β€’β€’ Premium profile

About Prasad Malurpatna Puttasiddaiah

Data last updated:

Prasad Malurpatna Puttasiddaiah was a Director at Sangenomics Research Labs Private Limited (from 2008) and Director at Sangene Biotech Private Limited (from 2004).

DIN 01110656
First Appointment 28 Oct 2004
Oldest Company Age 22 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jan 20082008Strike Off
Sangene Biotech Private Limited U08022KA2004PTC034930
Director28 Oct 20042004Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sangenomics Research Labs Private Limited
Sangene Biotech Private Limited
Premium access

Shareholding and investment profile for Prasad Malurpatna Puttasiddaiah

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Prasad Malurpatna Puttasiddaiah

Prasad Malurpatna Puttasiddaiah was first appointed on 28 Oct 2004 as Director at Sangene Biotech Private Limited. The most recent appointment on record is 28 Jan 2008 at Sangenomics Research Labs Private Limited.

Prasad Malurpatna Puttasiddaiah held 2 earlier board appointments: Sangenomics Research Labs Private Limited (Director, from 28 Jan 2008); Sangene Biotech Private Limited (Director, from 28 Oct 2004).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available